DE69622393D1 - Neue verwendung von pyrazolopyridinverbindungen - Google Patents
Neue verwendung von pyrazolopyridinverbindungenInfo
- Publication number
- DE69622393D1 DE69622393D1 DE69622393T DE69622393T DE69622393D1 DE 69622393 D1 DE69622393 D1 DE 69622393D1 DE 69622393 T DE69622393 T DE 69622393T DE 69622393 T DE69622393 T DE 69622393T DE 69622393 D1 DE69622393 D1 DE 69622393D1
- Authority
- DE
- Germany
- Prior art keywords
- new use
- pyrazolopyridine compounds
- dialysis
- chem
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000005229 pyrazolopyridines Chemical class 0.000 title 1
- 208000001953 Hypotension Diseases 0.000 abstract 2
- 238000000502 dialysis Methods 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 230000036543 hypotension Effects 0.000 abstract 2
- -1 pyrazolopyridine compound Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10358895 | 1995-04-27 | ||
| PCT/JP1996/001063 WO1996033715A1 (en) | 1995-04-27 | 1996-04-18 | Novel use of pyrazolopyridine compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69622393D1 true DE69622393D1 (de) | 2002-08-22 |
| DE69622393T2 DE69622393T2 (de) | 2002-11-28 |
Family
ID=14357939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69622393T Expired - Lifetime DE69622393T2 (de) | 1995-04-27 | 1996-04-18 | Neue verwendung von pyrazolopyridinverbindungen |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6232324B1 (de) |
| EP (1) | EP0823254B1 (de) |
| AT (1) | ATE220544T1 (de) |
| DE (1) | DE69622393T2 (de) |
| DK (1) | DK0823254T3 (de) |
| ES (1) | ES2176448T3 (de) |
| PT (1) | PT823254E (de) |
| WO (1) | WO1996033715A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2655362A1 (de) | 2010-12-22 | 2013-10-30 | Abbvie Inc. | Hepatitis-c-inhibitoren und ihre verwendung |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63135381A (ja) * | 1986-11-26 | 1988-06-07 | Kyorin Pharmaceut Co Ltd | 多剤耐性癌細胞に対する感受性増強剤及びその製造方法 |
| US4925849A (en) * | 1987-06-15 | 1990-05-15 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutically useful pyrazolopyridines |
-
1996
- 1996-04-18 WO PCT/JP1996/001063 patent/WO1996033715A1/ja not_active Ceased
- 1996-04-18 EP EP96910199A patent/EP0823254B1/de not_active Expired - Lifetime
- 1996-04-18 DE DE69622393T patent/DE69622393T2/de not_active Expired - Lifetime
- 1996-04-18 DK DK96910199T patent/DK0823254T3/da active
- 1996-04-18 PT PT96910199T patent/PT823254E/pt unknown
- 1996-04-18 US US08/945,175 patent/US6232324B1/en not_active Expired - Lifetime
- 1996-04-18 AT AT96910199T patent/ATE220544T1/de active
- 1996-04-18 ES ES96910199T patent/ES2176448T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0823254T3 (da) | 2002-11-04 |
| ATE220544T1 (de) | 2002-08-15 |
| EP0823254B1 (de) | 2002-07-17 |
| PT823254E (pt) | 2003-03-31 |
| ES2176448T3 (es) | 2002-12-01 |
| WO1996033715A1 (en) | 1996-10-31 |
| EP0823254A1 (de) | 1998-02-11 |
| DE69622393T2 (de) | 2002-11-28 |
| EP0823254A4 (de) | 1999-12-29 |
| US6232324B1 (en) | 2001-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69615674D1 (de) | Cyclobutan-derivate als inhibitoren der squalen-synthase und der protein farnesyltransferase | |
| FI862210A0 (fi) | Imidazoheterocykliska foereningar och foerfarande foer deras framstaellning. | |
| ATE247654T1 (de) | Neue heterozyklische verbindungen | |
| PT976748E (pt) | Derivados de pirrolidina com actividade inibidora de fosfolipase a2 | |
| HU9603433D0 (en) | Novel 4-6-diaryl-pyrimidine-derivatives and salts thereof | |
| DE60012751D1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| DK96786A (da) | Aminosyrederivater | |
| ES2096073T3 (es) | Derivado de benzamida. | |
| IL136100A (en) | Biphenylamidine derivatives and pharmaceutical compositions containing the same | |
| DE68926981D1 (de) | Cephemverbindungen und Verfahren zu ihrer Herstellung | |
| DK0420121T3 (da) | Antitumormiddel | |
| DE69315836D1 (de) | Pyrazolpyridine für die behandlung der anämie | |
| MX9206930A (es) | Nuevos compuestos | |
| DE69825981D1 (de) | 4,5-dihydroxy-2-cyclopenten-1-on für die Behandlung von Diabetes Mellitus | |
| DE69825977D1 (de) | Antivirale mittel | |
| ATE220544T1 (de) | Neue verwendung von pyrazolopyridinverbindungen | |
| DK0469833T3 (da) | N-benzylindoler, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende dem | |
| DE69001004D1 (de) | Zusammensetzung gegen leberkrankheiten. | |
| ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
| TW275629B (de) | ||
| ATE208761T1 (de) | Quinolin-derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8327 | Change in the person/name/address of the patent owner |
Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP |